Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,4.0X13: medical device reports filed with FDA

2,674 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

2,674
device reports naming the brand
0% of all MAUDE reports · about 382 a year
865
reports, 12 months to August 2026
664 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,674 medical device reports received by FDA name the brand "GM Helix Acqua Implant,Ti,4.0X13" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from July 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

865 reports arrived in the 12 months to August 2026, up 30% from 664 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (74.2%), loss of osseointegration (17.1%) and difficult to insert (1.5%). The patient problems coded most often are pain, fibrosis and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

078156Sep 2021: 11Oct 2021: 8Nov 2021: 16Dec 2021: 32022Jan 2022: 8Feb 2022: 11Mar 2022: 27Apr 2022: 25May 2022: 28Jun 2022: 21Jul 2022: 22Aug 2022: 34Sep 2022: 15Oct 2022: 20Nov 2022: 30Dec 2022: 262023Jan 2023: 27Feb 2023: 8Mar 2023: 10Apr 2023: 25May 2023: 28Jun 2023: 29Jul 2023: 26Aug 2023: 40Sep 2023: 38Oct 2023: 33Nov 2023: 30Dec 2023: 392024Jan 2024: 32Feb 2024: 48Mar 2024: 59Apr 2024: 56May 2024: 44Jun 2024: 33Jul 2024: 65Aug 2024: 43Sep 2024: 55Oct 2024: 51Nov 2024: 39Dec 2024: 382025Jan 2025: 52Feb 2025: 50Mar 2025: 56Apr 2025: 26May 2025: 0Jun 2025: 156Jul 2025: 64Aug 2025: 77Sep 2025: 57Oct 2025: 57Nov 2025: 51Dec 2025: 572026Jan 2026: 47Feb 2026: 68Mar 2026: 78Apr 2026: 75May 2026: 83Jun 2026: 96Jul 2026: 83Aug 2026: 113

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03527032019: 420192020: 5020202021: 11120212022: 26720222023: 33320232024: 56320242025: 70320252026: 6432026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,674
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report83.7%2,239
Voluntary report0%0
User facility report0%0
Distributor report16.3%435
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,98574.2%62.8%
Loss of osseointegration45717.1%22.4%
Difficult to insertthe device was hard to insert411.5%0.4%
Fracturea broken bone100.4%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified62723.4%
Fibrosis62423.3%
Inflammationinflammation1856.9%
Hemorrhage/blood loss/bleeding1575.9%
Swelling/ edema1214.5%
Hyperresponsive to stimuli732.7%
Fistula632.4%
Abscessa collection of pus582.2%
Hypersensitivity/allergic reaction250.9%
Tissue damage150.6%
Sinus perforation140.5%
Numbnessnumbness110.4%
Failure of implant30.1%
Inadequate osseointegration10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,4.0X13Product code DZEAll MAUDE reports
Reports2,6743,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer83.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,4.0X13 reports

How many FDA reports name GM Helix Acqua Implant,Ti,4.0X13?

2,674 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 865 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (74.2%), loss of osseointegration (17.1%), difficult to insert (1.5%) and fracture (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (83.7%) and distributor reports (16.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,4.0X13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.